Related Experiment Videos
Inflammatory markers and coronary artery disease
Stephan Fichtlscherer1, Christopher Heeschen, Andreas M Zeiher
1Johann W Goethe University, Department of Cardiology, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Current Opinion in Pharmacology
|April 6, 2004
Summary
Inflammation drives atherosclerosis. New inflammatory biomarkers identify unstable plaques, aiding diagnosis and risk stratification for coronary artery disease and acute coronary syndromes.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomarker Discovery
Background:
- Inflammatory processes are key to atherosclerosis development and progression.
- Recent advances have identified novel circulating biomarkers for atherosclerotic plaque instability.
Purpose of the Study:
- To highlight the role of newly identified inflammatory biomarkers.
- To discuss their utility in diagnosing acute coronary syndromes and stratifying cardiovascular risk.
Main Methods:
- Review of recent scientific literature on inflammatory biomarkers.
- Analysis of clinical applications in risk stratification.
Main Results:
- Several circulating inflammatory biomarkers indicate atherosclerotic plaque instability.
- These markers are valuable for identifying patients with unstable angina and acute myocardial infarction.
Conclusions:
- New inflammatory biomarkers are crucial for diagnosing acute coronary syndromes.
- They enable effective risk stratification in both stable and acute coronary artery disease settings.